Clinical Trial Update: TmCD19-IL18 in CD19+ Cancers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating TmCD19-IL18 for CD19-positive cancers, with Non-Hodgkin lymphoma as the condition, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• TmCD19-IL18

Snippet

Sponsor: University of Pennsylvania | Conditions: Non Hodgkin Lymphoma | Phase 1 | Status: RECRUITING